神威药业(02877)今日盘中股价大幅上涨5.09%，引起了市场的高度关注。
消息面上，公司于盘前发布了截至2025年12月31日止的年度业绩报告。报告显示，尽管面临市场挑战，公司年度净利润达到人民币9.5亿元，同比上升13.1%，展现了稳健的盈利能力。同时，公司宣布派发2026年第一次中期股息，每股人民币0.43元，体现了对股东回报的重视和公司良好的现金流状况。
此外，业绩报告中提到，公司有八个重磅产品在全国中成药采购联盟集中采购中中标，覆盖了心脑血管、呼吸系统等多个重要治疗领域。此举有助于公司产品进一步扩大市场份额，符合医保支付改革方向，为未来的销售增长奠定了坚实基础。这些积极的财务和业务进展共同提振了投资者信心，推动了股价在交易时段的显著上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.